92 results
Page 3 of 5
8-K
EX-99.1
bq1y jix1pllj5fb
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
EX-99.1
9mk9 rqayjc9mwre
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.1
927z0r4f
22 Nov 19
Other Events
5:01pm
424B5
sbtp35s3c7 n7yjbcty
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
5notno62evhd73c4 s8g
6 Nov 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
vdzrq0
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.2
4wf 84ra820syijms
4 May 18
Results of Operations and Financial Condition
7:07am